Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|August 19, 2010
Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor responseJianying Dong, Stephen J Demarest, Arlene Sereno, et al.
Neurosurgery|September 26, 2017
Long-Term Survivorship Following Stereotactic Radiosurgery Alone for Brain Metastases: Risk of Intracranial Failure and Implications for Surveillance and CounselingEmile Gogineni, John A Vargo, Scott M Glaser, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 28, 2020
Race-driven survival differential in women diagnosed with endometrial cancers in the USAZachary D Horne, Solomiya R Teterichko, Scott M Glaser, et al.
Gynecologic Oncology|June 23, 2018
Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vaginaBrian J Gebhardt, John A Vargo, Hayeon Kim, et al.
Brachytherapy|February 11, 2018
Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?Michael J Dohopolski, Zachary D Horne, Brian J Gebhardt, et al.
Mabs|September 12, 2023
Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disordersStephanie Maciuba, Gregory D Bowden, Harrison J Stratton, et al.
Gynecologic Oncology|June 13, 2025
Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer: A multicenter studyAnupam Rishi, Kevin V Albuquerque, Anuja Jhingran, et al.
Mabs|January 12, 2010
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaRJennifer S Michaelson, Stephen J Demarest, Brian Miller, et al.
Cell|August 22, 2020
A Human IgSF Cell-Surface Interactome Reveals a Complex Network of Protein-Protein InteractionsWoj M Wojtowicz, Jost Vielmetter, Ricardo A Fernandes, et al.
The Journal of Biological Chemistry|December 3, 2010
Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activityJianying Dong, Arlene Sereno, William B Snyder, et al.
Pageof 6